Subcutaneous Immunoglobulin Therapy In The Chronic Management Of Myasthenia Gravis.

Simple item page
dc.contributor.authorAlfituri, Nadia Abdelsalam Omran
dc.date.accessioned2018-01-23T12:09:08Z
dc.date.available2018-01-23T12:09:08Z
dc.date.issued2017-02-21
dc.description.abstractSubcutaneous immunoglobulin therapy has been recently researched and shown to be favorable and to have advantages over intravenous immunoglobulin therapy, in the chronic management of myasthenia gravis. This report aims to discuss the findings of research into this new long term therapy option for myasthenia gravis.en_US
dc.identifier.urihttp://repository.limu.edu.ly/handle/123456789/168
dc.language.isoenen_US
dc.publisherFaculty of Basic Medical Science - Libyan International Medical Universityen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subjectSubcutaneous immunoglobulin therapyen_US
dc.titleSubcutaneous Immunoglobulin Therapy In The Chronic Management Of Myasthenia Gravis.en_US
dc.title.alternativeSubcutaneous immunoglobulin therapyen_US
dc.typeTechnical Reporten_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Subcutaneous Immunoglobulin Therapy.pdf
Size:
379.47 KB
Format:
Adobe Portable Document Format
Description:
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.74 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Student Report